Overview
The GHK-Cu / BPC-157 / TB-500 Blend is a specialized research formulation combining three extensively studied laboratory-synthesized peptides: GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper Complex), BPC-157 (Body Protection Compound-157), and TB-500 (Thymosin Beta-4 Fragment).
In experimental biology, this combination is utilized to investigate synergistic mechanisms of action across multiple physiological systems. By targeting distinct signaling pathways—specifically actin cytoskeletal regulation (TB-500), nitric oxide and angiogenic signaling (BPC-157), and collagen synthesis/redox regulation (GHK-Cu)—this blend serves as a comprehensive tool for studying systemic tissue remodeling, wound healing kinetics, and cellular recovery under stress conditions.
Molecular & Biochemical Properties
This product is a lyophilized mixture containing the following three peptide components:
1. TB-500 (Thymosin Beta-4 Fragment)
- Amino Acid Sequence: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser
- Molecular Formula: C₂₁₂H₃₅₀N₅₆O₇₈S
- Molecular Weight: 4,963.44 g/mol
- Primary Function: Actin sequestration and cytoskeletal organization.
2. BPC-157 (Pentadecapeptide)
- Amino Acid Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
- Molecular Formula: C₆₂H₉₈N₁₆O₂₂
- Molecular Weight: 1,419.56 g/mol
- Primary Function: Angiogenic signaling (VEGFR2) and focal adhesion remodeling.
3. GHK-Cu (Copper Tripeptide-1)
- Amino Acid Sequence: Gly-His-Lys (Cu²⁺)
- Molecular Formula: C₁₄H₂₃CuN₆O₄
- Molecular Weight: 401.91 g/mol
- Primary Function: Extracellular matrix synthesis, copper transport, and redox regulation.
Research Applications
This tri-peptide blend is utilized exclusively within laboratory research workflows to evaluate multi-faceted cellular phenotypes. Common experimental applications include:
- Musculoskeletal & Connective Tissue Models: Investigating the concurrent repair of tendons (BPC-157), muscle fibers (TB-500), and collagen matrices (GHK-Cu).
- Angiogenesis & Vascular Biology: Assessing tube formation and endothelial cell migration through combined VEGF-axis transcriptional activity and nitric oxide pathways.
- Dermal Remodeling & Wound Assays: Studying fibroblast migration, extracellular matrix (ECM) restructuring, and hair follicle phenotypes in skin-focused experimental systems.
- Oxidative Stress & Inflammation: Evaluating the modulation of pro-inflammatory cytokines and antioxidant response elements (via Copper chelation and innate signaling axes).
- Neuronal Support: Examining neurite extension and glial cell responses in neurodegeneration-adjacent models.
Mechanistic & Pathway Context
Research suggests that combining these peptides may influence overlapping signaling networks:
- Cytoskeletal Dynamics: TB-500 regulates the G-actin/F-actin balance, essential for cell motility, while BPC-157 alters phosphorylation patterns of focal adhesion proteins to guide migration.
- Matrix Synthesis: GHK-Cu facilitates the transport of copper ions necessary for lysyl oxidase (an enzyme critical for collagen cross-linking), complementing the ECM-remodeling effects of BPC-157 and TB-500.
- Regenerative Signaling: The blend allows researchers to observe the interplay between Integrin signaling (GHK), VEGFR2 pathways (BPC), and actin-dependent networks (TB) simultaneously.
Summary of Preclinical Research Contexts
- Tendon & Ligament: Rodent studies involving BPC-157 have reported improved healing in transected ligaments, while TB-500 is associated with myocyte repair.
- Skin & Hair: GHK-Cu is extensively documented in in-vitro fibroblast models for collagen stimulation; TB-500 has been studied for its role in hair follicle stem cell migration.
- Vascular Repair: In ischemia-reperfusion models, both BPC-157 and TB-500 have demonstrated the ability to promote revascularization and protect endothelial integrity.
Formulation & Quality Verification
The GHK/BPC/TB blend is supplied as a sterile, lyophilized powder intended for controlled laboratory use. Each component is manufactured via solid-phase peptide synthesis. Identity and purity are confirmed using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) as part of standard quality control procedures.
Research Use Only (RUO) Disclaimer
All products available on this website are supplied solely for in-vitro laboratory research purposes. In-vitro studies are conducted outside of living organisms under controlled experimental conditions.
These materials are not pharmaceuticals, drugs, or therapeutic agents and have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, mitigation, or prevention of any disease or medical condition.
